Science & tech

Science & tech

MendelScan—AI for good: informing patient and public perception

By editor

7 October 2024

Science & tech

Improved patient finding strategies for rare diseases – a win-win for patients and drug developers

By CONTRIBUTOR

25 September 2024

Science & tech

Precision in patient data: How genetic databases are helping to shape rare disease population studies

By CONTRIBUTOR

8 May 2024

Science & tech

Beyond development: Overcoming market access challenges for rare disease treatment

By CONTRIBUTOR

28 February 2024

Science & tech

Dr Wendy Chung and Simons Searchlight: pioneering research into genes that cause rare neurodevelopmental disorders

By CONTRIBUTOR

21 February 2024

Science & tech

Faster diagnosis for patients with rare diseases

By CONTRIBUTOR

24 January 2024

Science & tech

The Undiagnosed Diseases Network’s mission to eradicate the diagnostic odyssey: an interview with Sarah Marshall

By CONTRIBUTOR

6 December 2023

Science & tech

What is a flare in Sjögren’s? TREND Community’s innovative use of artificial intelligence to find answers for the community

By CONTRIBUTOR

8 November 2023

Science & tech

Marie Curie: the inspiring legacy of a great woman of science and our RARE inspiration

By CONTRIBUTOR

16 August 2023

Science & tech

LifeArc announces investment of more than £100 million into rare disease research by 2030

By CONTRIBUTOR

6 July 2023

Science & tech

Engaging patients to shape the research of the future

By CONTRIBUTOR

21 April 2023

Science & tech

Optimising market access for rare disease products: insights from Craig Caceci

By CONTRIBUTOR

27 February 2023

Science & tech

The real-world evidence revolution: how better research can improve patients’ lives

By CONTRIBUTOR

27 October 2022

Science & tech

Merging the metaverse and the rare disease community: join the conversation

By CONTRIBUTOR

22 September 2022

Science & tech

World Orphan Drug Alliance (WODA): bringing therapies to underserved patients around the globe

By CONTRIBUTOR

6 July 2022

Science & tech

Sure, you’ve heard about GNEM. But do you know about the Bulgarian variant?

By CONTRIBUTOR

19 May 2022

Science & tech

Building a bridge between patient and pharma: the CMT story

By CONTRIBUTOR

9 May 2022

1 2 Next »